Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 8/20 | 0.43 |
| ▸ | TDO2 | P48775 | 8/20 | 0.43 |
| ▸ | DPP4 | P27487 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | SCN1A | P35498 | 3/20 | 0.40 |
| ▸ | SCN2A | Q99250 | 3/20 | 0.40 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.40 |
| ▸ | IDO2 | Q6ZQW0 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3482548 | 0.86 | MEN1 (0.43) | IDO1TDO2TSHRSCN1ASCN2A | |
| SCHEMBL18297945 | 0.78 | ESR1 (0.57) | IDO1TDO2IDO2LMNACHRM2 | |
| SCHEMBL21382043 | 0.76 | SCN1A (0.37) | IDO1TDO2TSHRSCN1ASCN2A | |
| SCHEMBL127629 | 0.75 | IDO1 (0.46) | IDO1TDO2DPP4TSHRF2 | |
| Methane SCHEMBL29089947 | 0.73 | IDO1 (0.44) | IDO1TDO2DPP4TSHRF2 | |
| Ammonia Solution, Strong SCHEMBL7282272 | 0.73 | IDO1 (0.44) | IDO1TDO2DPP4TSHRF2 | |
| Water SCHEMBL11878861 | 0.73 | IDO1 (0.44) | IDO1TDO2DPP4TSHRF2 | |
| SCHEMBL5168139 | 0.72 | CHRNA7 (0.42) | IDO1TDO2KDM4E | |
| SCHEMBL8923611 | 0.72 | CES2 (0.41) | IDO1TDO2DPP4TSHRF2 | |
| SCHEMBL8923168 | 0.72 | LMNA (0.44) | DPP4TSHRLMNAADRA2ACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 436 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250329799-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY SAFETY | Anthro Energy, Inc. (US) | 2025-10-23 | — | — | US | claimed |
| CN-115181223-B | Low-gloss matte auxiliary agent, preparation method thereof and molded body | 铨盛聚碳科技股份有限公司 | 2023-08-29 | — | — | CN | claimed |
| US-20200332149-A1 | ORGANOFUNCTIONAL SILOXANES, PROCESS FOR PREPARING SAME AND THEIR USE FOR THE TREATMENT OF FILLINGS AND SURFACES | ABCR LABORATORIOS, S.L. (ES) | 2020-10-22 | — | — | US | claimed |
| EP-3543304-A1 | ORGANOFUNCTIONAL SILOXANES, METHOD FOR ITS PREPARATION AND USE FOR THE TREATMENT OF FILLERS AND SURFACES | ABCR Laboratorios, S.L. (ES) | 2019-09-25 | — | — | EP | claimed |
| EP-2812360-A2 | HYDROPHILIC POLYMERIC PARTICLES AND METHODS FOR MAKING SAME | Life Technologies Corporation (US) | 2014-12-17 | — | — | EP | claimed |
| WO-2013119936-A2 | HYDROPHILIC POLYMERIC PARTICLES AND METHODS FOR MAKING SAME | Life Technologies Corporation (US) | 2013-08-15 | — | — | WO | claimed |
| CN-101495657-A | Nucleic Acid Amplification Using Reversibly Modified Oligonucleotides | WANLI BI (US) | 2009-07-29 | — | — | CN | claimed |
| WO-2007102652-A1 | METHOD OF POLYMERIZING PROPYLENE COMPRISING OLEFIN PRE-POLYMERIZATION STEP | LG CHEM, LTD. (KR) | 2007-09-13 | — | — | WO | claimed |
| US-20070208147-A1 | METHOD OF POLYMERIZING PROPYLENE COMPRISING OLEFIN PRE-POLYMERIZATION STEP | LG CHEM, LTD. (KR) | 2007-09-06 | — | — | US | claimed |
| EP-1287043-B1 | A METHOD FOR PRODUCING ETHYLENE HOMO- AND CO-POLYMER | SAMSUNG GENERAL CHEMICALS CO (KR) | 2005-11-23 | — | — | EP | claimed |
| US-6376615-B1 | USING FREE RADICALS | CENTRO DE INVESTIGACION EN QUIMICA APLICADA (MX) | 2002-04-23 | — | — | US | claimed |
| US-20020037980-A1 | Method for producing ethylene homo- and co-polymer | SAMSUNG GENERAL CHEMICALS CO., LTD. (KR) | 2002-03-28 | — | — | US | claimed |
| US-20020012850-A1 | Silane compounds as additive in electrolytes for electrochemical cells | MERCK PATENTGESELLSCHAFT (DE) | 2002-01-31 | — | — | US | claimed |
| CN-1328355-A | Silane compound used as additives of electrochemical accumulator electrolyte | MERCK PATENT GMBH (DE) | 2001-12-26 | — | — | CN | claimed |
| EP-1162682-A1 | Silane compounds as additives in electrolytes of electrochemical cells | MERCK PATENT GmbH (DE) | 2001-12-12 | — | — | EP | claimed |
| WO-2001092345-A1 | A METHOD FOR PRODUCING ETHYLENE HOMO- AND CO-POLYMER | SAMSUNG GENERAL CHEMICALS CO., LTD. (KR) | 2001-12-06 | — | — | WO | claimed |
| EP-0990014-B1 | PIGMENTED POROUS MATERIAL | CIBA SC HOLDING AG (CH) | 2001-08-29 | — | — | EP | claimed |
| US-20010012559-A1 | Colored porous material such as leather, imitation leather, chalk, wood, and concrete having organic pigment in its pores obtainable by fragmenting a meltable or solvent soluble pigment precursor | CIBA SPECIALTY CHEMICALS CORP | 2001-08-09 | — | — | US | claimed |
| EP-0990014-A1 | PIGMENTED POROUS MATERIAL | Ciba SC Holding AG (CH) | 2000-04-05 | — | — | EP | claimed |
| WO-1998058027-A1 | PIGMENTED POROUS MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1998-12-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200332149-A1 | ORGANOFUNCTIONAL SILOXANES, PROCESS FOR PREPARING SAME AND THEIR USE FOR THE TREATMENT OF FILLINGS AND SURFACES | FDFT1, DBF4, IPO4 | IDO1 1306/4885TDO2 393/4885DPP4 790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.